Skip to main content
Top
Published in: BMC Clinical Pharmacology 1/2010

Open Access 01-12-2010 | Research article

Characteristics of primary health care units with focus on drug information from the pharmaceutical industry and adherence to prescribing objectives: a cross-sectional study

Authors: Daniel Carlzon, Lena Gustafsson, Anna L Eriksson, Karin Rignér, Anders Sundström, Susanna M Wallerstedt

Published in: BMC Clinical Pharmacology | Issue 1/2010

Login to get access

Abstract

Background

Adherence to prescribing guidelines varies between primary health care units. The aim of the present study was to investigate correlations between characteristics of primary health care units and adherence to prescribing objectives for rational drug use with focus on drug information from the pharmaceutical industry.

Methods

A cross-sectional study was performed in all 25 primary health care units in Göteborg, Sweden. A questionnaire on characteristics of practice settings [(i) size of unit, (ii) profession of head, (iii) use of temporary physicians, (iv) drug information from the pharmaceutical industry, (v) producer-independent drug information, and (vi) education on prescribing for newly employed physicians] was sent to the heads of the units. A national sales register for prescribed drugs (Xplain) was used for evaluation of adherence to the six regional prescribing objectives concerning proton pump inhibitors (PPIs), angiotensin converting enzyme inhibitors (ACEIs), statins and antidepressants.

Results

Twenty-two out of 25 primary health care units responded to the questionnaire (response rate 88%). A physician as head and presence of producer-independent drug information was positively correlated with adherence to the prescribing objectives (median number of prescribing objectives adhered to (25th - 75th percentile): 2.5 (1-3.25) vs 1 (0-2), P = 0.013; 2 (1-3) vs 0, P = 0.043, respectively. Presence of drug information from the pharmaceutical industry and education on prescribing for newly employed physicians was negatively associated with adherence to the prescribing objectives: 1 (0-2) vs 3.5 (2.25-4.75), P = 0.005; 1 (0-2) vs 3 (1.5-4), P = 0.034, respectively.

Conclusion

Several characteristics of the primary health care units correlated with adherence to prescribing objectives for rational drug use. Further research on this topic is needed and would constitute valuable information for health care decision makers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hoffman JM, Shah ND, Vermeulen LC, Doloresco F, Grim P, Hunkler RJ, Hontz KM, Schumock GT: Projecting future drug expenditures--2008. Am J Health Syst Pharm. 2008, 65 (3): 234-253. 10.2146/ajhp070629.CrossRefPubMed Hoffman JM, Shah ND, Vermeulen LC, Doloresco F, Grim P, Hunkler RJ, Hontz KM, Schumock GT: Projecting future drug expenditures--2008. Am J Health Syst Pharm. 2008, 65 (3): 234-253. 10.2146/ajhp070629.CrossRefPubMed
2.
go back to reference Ohlsson H, Lindblad U, Lithman T, Ericsson B, Gerdtham UG, Melander A, Rastam L, Merlo J: Understanding adherence to official guidelines on statin prescribing in primary health care--a multi-level methodological approach. Eur J Clin Pharmacol. 2005, 61 (9): 657-665. 10.1007/s00228-005-0975-9.CrossRefPubMed Ohlsson H, Lindblad U, Lithman T, Ericsson B, Gerdtham UG, Melander A, Rastam L, Merlo J: Understanding adherence to official guidelines on statin prescribing in primary health care--a multi-level methodological approach. Eur J Clin Pharmacol. 2005, 61 (9): 657-665. 10.1007/s00228-005-0975-9.CrossRefPubMed
3.
go back to reference Kasje WN, Denig P, Stewart RE, de Graeff PA, Haaijer-Ruskamp FM: Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study. Eur J Clin Pharmacol. 2005, 61 (2): 145-151. 10.1007/s00228-005-0897-6.CrossRefPubMed Kasje WN, Denig P, Stewart RE, de Graeff PA, Haaijer-Ruskamp FM: Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study. Eur J Clin Pharmacol. 2005, 61 (2): 145-151. 10.1007/s00228-005-0897-6.CrossRefPubMed
4.
go back to reference Tamblyn R, McLeod P, Hanley JA, Girard N, Hurley J: Physician and practice characteristics associated with the early utilization of new prescription drugs. Med Care. 2003, 41 (8): 895-908. 10.1097/00005650-200308000-00004.CrossRefPubMed Tamblyn R, McLeod P, Hanley JA, Girard N, Hurley J: Physician and practice characteristics associated with the early utilization of new prescription drugs. Med Care. 2003, 41 (8): 895-908. 10.1097/00005650-200308000-00004.CrossRefPubMed
5.
go back to reference Kozyrskyj A, Raymond C, Racher A: Characterizing early prescribers of newly marketed drugs in Canada: a population-based study. Eur J Clin Pharmacol. 2007, 63 (6): 597-604. 10.1007/s00228-007-0277-5.CrossRefPubMed Kozyrskyj A, Raymond C, Racher A: Characterizing early prescribers of newly marketed drugs in Canada: a population-based study. Eur J Clin Pharmacol. 2007, 63 (6): 597-604. 10.1007/s00228-007-0277-5.CrossRefPubMed
6.
go back to reference Ohlsson H, Merlo J: Understanding the effects of a decentralized budget on physicians' compliance with guidelines for statin prescription--a multilevel methodological approach. BMC Health Serv Res. 2007, 7: 68-10.1186/1472-6963-7-68.CrossRefPubMedPubMedCentral Ohlsson H, Merlo J: Understanding the effects of a decentralized budget on physicians' compliance with guidelines for statin prescription--a multilevel methodological approach. BMC Health Serv Res. 2007, 7: 68-10.1186/1472-6963-7-68.CrossRefPubMedPubMedCentral
7.
go back to reference Sturm HB, van Gilst WH, Veeger N, Haaijer-Ruskamp FM: Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey. Pharmacoepidemiol Drug Saf. 2007, 16 (1): 96-103. 10.1002/pds.1216.CrossRefPubMed Sturm HB, van Gilst WH, Veeger N, Haaijer-Ruskamp FM: Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey. Pharmacoepidemiol Drug Saf. 2007, 16 (1): 96-103. 10.1002/pds.1216.CrossRefPubMed
8.
go back to reference Edward C, Himmelmann A, Wallerstedt SM: Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study. BMC Clin Pharmacol. 2007, 7: 12-10.1186/1472-6904-7-12.CrossRefPubMedPubMedCentral Edward C, Himmelmann A, Wallerstedt SM: Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study. BMC Clin Pharmacol. 2007, 7: 12-10.1186/1472-6904-7-12.CrossRefPubMedPubMedCentral
9.
go back to reference Ohlsson H, Merlo J: Is physician adherence to prescription guidelines a general trait of health care practices or dependent on drug type?--a multilevel logistic regression analysis in South Sweden. Pharmacoepidemiol Drug Saf. 2009, 18 (8): 682-690. 10.1002/pds.1767.CrossRefPubMed Ohlsson H, Merlo J: Is physician adherence to prescription guidelines a general trait of health care practices or dependent on drug type?--a multilevel logistic regression analysis in South Sweden. Pharmacoepidemiol Drug Saf. 2009, 18 (8): 682-690. 10.1002/pds.1767.CrossRefPubMed
10.
go back to reference de Bakker DH, Coffie DS, Heerdink ER, van Dijk L, Groenewegen PP: Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis. BMC Health Serv Res. 2007, 7: 132-10.1186/1472-6963-7-132.CrossRefPubMedPubMedCentral de Bakker DH, Coffie DS, Heerdink ER, van Dijk L, Groenewegen PP: Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis. BMC Health Serv Res. 2007, 7: 132-10.1186/1472-6963-7-132.CrossRefPubMedPubMedCentral
11.
go back to reference Caamano F, Figueiras A, Gestal-Otero JJ: Influence of commercial information on prescription quantity in primary care. Eur J Public Health. 2002, 12 (3): 187-191. 10.1093/eurpub/12.3.187.CrossRefPubMed Caamano F, Figueiras A, Gestal-Otero JJ: Influence of commercial information on prescription quantity in primary care. Eur J Public Health. 2002, 12 (3): 187-191. 10.1093/eurpub/12.3.187.CrossRefPubMed
12.
go back to reference Caudill TS, Johnson MS, Rich EC, McKinney WP: Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med. 1996, 5 (4): 201-206. 10.1001/archfami.5.4.201.CrossRefPubMed Caudill TS, Johnson MS, Rich EC, McKinney WP: Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med. 1996, 5 (4): 201-206. 10.1001/archfami.5.4.201.CrossRefPubMed
Metadata
Title
Characteristics of primary health care units with focus on drug information from the pharmaceutical industry and adherence to prescribing objectives: a cross-sectional study
Authors
Daniel Carlzon
Lena Gustafsson
Anna L Eriksson
Karin Rignér
Anders Sundström
Susanna M Wallerstedt
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Clinical Pharmacology / Issue 1/2010
Electronic ISSN: 1472-6904
DOI
https://doi.org/10.1186/1472-6904-10-4

Other articles of this Issue 1/2010

BMC Clinical Pharmacology 1/2010 Go to the issue